|
Market Closed -
NYSE
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.9783 USD | -1.21% |
|
-1.58% | -41.42% |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 247M 220M 204M 185M 350M 23.48B 356M 2.45B 961M 12.25B 929M 909M 39.06B | P/E 2026 * |
-16.3x | P/E 2027 * | -7.62x |
|---|---|---|---|---|---|
| Enterprise Value | 247M 220M 204M 185M 350M 23.48B 356M 2.45B 961M 12.25B 929M 909M 39.06B | EV / Sales 2026 * |
16.3x | EV / Sales 2027 * | 14.7x |
| Free-Float |
95.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
|
Tradegate
| BT3 | Real-time | |
|
Deutsche Boerse AG
| BT3 | Delayed | |
|
Börse Stuttgart
| BT3 | Delayed | |
|
Boerse Muenchen
| BT3 | Real-time |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | -1.21% | ||
| 1 week | -1.58% | ||
| Current month | +2.36% | ||
| 1 month | -5.02% | ||
| 3 months | -15.66% | ||
| 6 months | -42.79% | ||
| Current year | -41.42% |
| 1 week | 0.89 |  | 1 |
| 1 month | 0.88 | | 1.05 |
| Current year | 0.88 | | 1.98 |
| 1 year | 0.88 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 2018-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 2022-11-13 |
Priyantha Herath
CTO | Chief Tech/Sci/R&D Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 2009-06-30 |
Deborah Andrews
BRD | Director/Board Member | 68 | 2014-04-10 |
Michael Mulroy
CHM | Chairman | 60 | 2024-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Free | Director | 125,000 | 0.0501% | ||
| 7/1/26 | Broadwood Capital, Inc.
| Free | Company | 125,000 | 0.0501% | |
| 7/1/26 | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | -1.58% | -40.71% | -19.15% | 247M | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +0.73% | +5.89% | +9.91% | +77.72% | 51.2B | |
| -0.14% | -0.90% | -0.47% | +61.18% | 51.19B | |
| -1.53% | +2.70% | +30.48% | +41.25% | 43.93B | |
| -1.34% | +4.12% | +16.64% | +120.28% | 41.96B | |
| -5.97% | -6.22% | +228.95% | +483.48% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| -0.32% | +0.16% | +25.40% | +25.43% | 22.5B | |
| Average | -0.70% | -0.03% | +37.79% | +91.91% | 37.26B | |
| Weighted average by Cap. | -0.48% | +0.04% | +44.91% | +105.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.19M 13.51M 12.52M 11.39M 21.49M 1.44B 21.84M 150M 58.99M 752M 57.02M 55.81M 2.4B | 16.83M 14.96M 13.87M 12.62M 23.81M 1.6B 24.19M 167M 65.37M 834M 63.18M 61.83M 2.66B |
| Net income | -22.64M -20.13M -18.65M -16.97M -32.03M -2.15B -32.54M -224M -87.91M -1.12B -84.97M -83.16M -3.57B | -34.44M -30.61M -28.37M -25.82M -48.72M -3.27B -49.5M -341M -134M -1.71B -129M -127M -5.44B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | US$0.9783 | -1.21% | 1,308,653 |
| 26-10-15 | US$0.9903 | +7.93% | 1,424,713 |
| 26-10-14 | US$0.9175 | +1.01% | 2,201,249 |
| 26-10-13 | US$0.9083 | -4.80% | 1,784,674 |
| 26-10-12 | US$0.9541 | -4.01% | 1,686,970 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
